Literature DB >> 17133452

Preparation and preliminary characterization of concentric multi-walled chitosan microspheres.

Shwu Jen Chang1, Gregory Cheng-Chie Niu, Shyh Ming Kuo, Shu Fen Chen.   

Abstract

Chitosan was first converted into micro-droplets by using a high voltage electrostatic field system. The droplets were then dropped into a series of Na(5)P(3)O(10)/NaOH solution mixtures with volume ratio of 17:3, 19:1, 1:0 (pure aqueous Na(5)P(3)O(10)) or 0:1 (pure aqueous NaOH) in order to fabricate chitosan microspheres with different membrane structures. The microspheres exhibit distinct chemical and physical properties, including release behaviors of encapsulated drugs. These chitosan microspheres prepared by this method exhibited good sphericity within the range of (286.6 +/- 15.9) to (356 +/- 9.5) microm in diameters. SEM observations have indicated that the chitosan microspheres exhibited distinct surface structures depending on the post-treatment solutions. The mechanical strength of the chitosan microspheres significantly improved upon treatment with Na(5)P(3)O(10)/NaOH solution at ratio of 17:3 (v/v), as compared with the same but at ratio of 19:1, 1:0 (pure Na(5)P(3)O(10)) and 0:1 (pure NaOH) solutions. In addition, chitosan microspheres with unique multi-walled concentric shell membrane structures were prepared by treating with Na(5)P(3)O(10)/NaOH solution at ratio of 19:1. Release studies were carried out to evaluate the kinetic profiles of two model drugs (5-fluorouracil and cytochrome C) from these prepared chitosan microspheres. When chitosan microspheres treated with Na(5)P(3)O(10)/NaOH ratio at 17:3, the release of cytochrome C was found to be the slowest as compared to those treated by the same Na(5)P(3)O(10)/NaOH solution of other mixing ratios, after a period of 35-day "endurance" test. However, in one case, 5-fluorouracil released quite quickly in a period of 30 min (about 80% completion). The wide range of drug release results might be attributed to the unique and wide range of surface characteristics, porosities, and various structures of chitosan microspheres upon treatment with Na(5)P(3)O(10)/NaOH solutions. These results indicate that, by adjusting the Na(5)P(3)O(10)/NaOH ratios, without extra manipulation on polymer material formulation, one could obtain an additional degree of freedom in drug release profile that permits the simultaneous regulation of morphologies of surface texture and internal structure, mechanical properties, and molecular permeability of the microspheres.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133452     DOI: 10.1002/jbm.a.31084

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study.

Authors:  Farhan Ahmed; Sonali Kumari; Anand Kumar Kondapi
Journal:  Pharm Res       Date:  2018-07-16       Impact factor: 4.200

2.  Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies.

Authors:  Tugba Basargan; Nalan Erdol-Aydin; Gulhayat Nasun-Saygili
Journal:  J Mater Sci Mater Med       Date:  2017-10-06       Impact factor: 3.896

3.  Formulation development and rheological studies of palatable cefetamet pivoxil hydrochloride dry powder suspension.

Authors:  Sb Sateesha; Aj Rajamma; Hs Shekar; G Divakar
Journal:  Daru       Date:  2011       Impact factor: 3.117

4.  One-Step Method to Prepare PLLA Porous Microspheres in a High-Voltage Electrostatic Anti-Solvent Process.

Authors:  Ying Wang; Li-Hui Zhu; Ai-Zheng Chen; Qiao Xu; Yu-Juan Hong; Shi-Bin Wang
Journal:  Materials (Basel)       Date:  2016-05-13       Impact factor: 3.623

Review 5.  Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.

Authors:  José L Arias
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411

6.  Rabbit as an Animal Model for Pharmacokinetics Studies of Enteric Capsule Contains Recombinant Human Keratinocyte Growth Factor Loaded Chitosan Nanoparticles.

Authors:  Palanirajan V Kumar; Marwan A Abdelkarim Maki; Yeong S Wei; Lee M Tatt; Manogaran Elumalai; Shiau-Chuen Cheah; Bharathy Raghavan; Abu Bakar Bin A Majeed
Journal:  Curr Clin Pharmacol       Date:  2019
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.